Personalized medicine—but this time for real!

Peter Kapitein


Personalized Medicine is not a new treatment for patients with more possibilities for the stakeholders in the medical industrial complex. It’s the hope for patients to get a treatment on an individual level: this patient, with her specific defect, needs a treatment at this moment. With the modern technologies of pathology, imaging, sequencing and proteomics we can realize a lot but not enough. We need more and better molecular testing to realize our goal and transferring hope into a better quality of live. Several hurdles need to be taken. This is possible when cooperation of the stakeholders takes place. And when there is the urgency, opportunity and willingness to change. Some other industries have done it before so why should healthcare not be able to do so?